Found: 148
Select item for more details and to access through your institution.
Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell Carcinoma.
- Published in:
- International Journal of Spine Surgery, 2024, v. 18, n. 3, p. 343, doi. 10.14444/8608
- By:
- Publication type:
- Article
PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy.
- Published in:
- BJU International, 2024, v. 133, n. 4, p. 425, doi. 10.1111/bju.16217
- By:
- Publication type:
- Article
Microbiome subsets determine tumor prognosis and molecular characteristics of clear-cell renal cell carcinoma: a multi-center integrated analysis of microbiome, metabolome, and transcriptome data.
- Published in:
- 2024
- By:
- Publication type:
- Letter
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 2, p. 179, doi. 10.1007/s10637-024-01419-1
- By:
- Publication type:
- Article
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 254, doi. 10.1093/oncolo/oyad348
- By:
- Publication type:
- Article
Managing Toxicities of Checkpoint Inhibitors: A Urologist's Guide.
- Published in:
- AUANews, 2023, p. 20
- By:
- Publication type:
- Article
Phase 1b/2 trial of Ipilimumab, Nivolumab, and Ciforadenant (INC) (adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma.
- Published in:
- Oncologist, 2023, v. 28, p. S13, doi. 10.1093/oncolo/oyad216.022
- By:
- Publication type:
- Article
OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC).
- Published in:
- Oncologist, 2023, v. 28, p. S14, doi. 10.1093/oncolo/oyad216.023
- By:
- Publication type:
- Article
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 494, doi. 10.1093/oncolo/oyad028
- By:
- Publication type:
- Article
Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta‐analysis.
- Published in:
- BJU International, 2023, v. 131, n. 5, p. 553, doi. 10.1111/bju.15981
- By:
- Publication type:
- Article
COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 5, p. 597, doi. 10.1093/jnci/djad015
- By:
- Publication type:
- Article
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated with Axitinib: Subgroup Analysis from TIVO-3.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e167, doi. 10.1093/oncolo/oyac255
- By:
- Publication type:
- Article
Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41419-023-05566-w
- By:
- Publication type:
- Article
Experts Discuss Treatment Methodologies in RCC.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 1, p. 36
- By:
- Publication type:
- Article
Treatment of Refractory Metastatic Renal Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5005, doi. 10.3390/cancers14205005
- By:
- Publication type:
- Article
Emerging Targets in Clear Cell Renal Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4843, doi. 10.3390/cancers14194843
- By:
- Publication type:
- Article
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 5, p. 454, doi. 10.3322/caac.21729
- By:
- Publication type:
- Article
The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3830, doi. 10.3390/cancers14153830
- By:
- Publication type:
- Article
Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 511
- By:
- Publication type:
- Article
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2085, doi. 10.1002/cncr.34180
- By:
- Publication type:
- Article
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 6, p. 695, doi. 10.1007/s11912-022-01196-1
- By:
- Publication type:
- Article
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.662723
- By:
- Publication type:
- Article
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 154, doi. 10.1007/s10147-021-02014-7
- By:
- Publication type:
- Article
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.
- Published in:
- Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00334-4
- By:
- Publication type:
- Article
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 633, doi. 10.1007/s11523-021-00832-3
- By:
- Publication type:
- Article
Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e835, doi. 10.1093/cid/ciaa1571
- By:
- Publication type:
- Article
Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.609235
- By:
- Publication type:
- Article
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2662, doi. 10.3390/cancers12092662
- By:
- Publication type:
- Article
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 4, p. 477, doi. 10.1007/s11523-020-00734-w
- By:
- Publication type:
- Article
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
- Published in:
- BJU International, 2020, v. 126, n. 1, p. 73, doi. 10.1111/bju.15058
- By:
- Publication type:
- Article
Descriptive comparison of hospital formulary decisions with published oncology valuation methods.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 891, doi. 10.1177/1078155219877927
- By:
- Publication type:
- Article
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
- Published in:
- Journal of Neurosurgery, 2020, v. 132, n. 1, p. 188, doi. 10.3171/2018.8.JNS182100
- By:
- Publication type:
- Article
Adjuvant therapy in renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association of PD-L1, PD-L2, and Immune Response Markers in Matched Renal Clear Cell Carcinoma Primary and Metastatic Tissue Specimens.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
HIF Inhibitors: Status of Current Clinical Development.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0752-z
- By:
- Publication type:
- Article
Cases from the irAE Tumor Board: A Multidisciplinary Approach to a Patient Treated with Immune Checkpoint Blockade Who Presented with a New Rash.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 4, doi. 10.1634/theoncologist.2018-0434
- By:
- Publication type:
- Article
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo‐hormonal therapy.
- Published in:
- Prostate, 2018, v. 78, n. 13, p. 1035, doi. 10.1002/pros.23663
- By:
- Publication type:
- Article
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article